Combines Extensive Contact Lens & Pharma Experience
Intellectual Property
Intellectual Property
Freya Technology is Well Protected by Patents and Licenses
![Technology License](https://freyaophthalmics.com/wp-content/uploads/2023/10/unnamed-11.png)
Technology License
Exclusive worldwide license to drug delivery contact lens technology from the University of Florida through 2029
![Trademarks](https://freyaophthalmics.com/wp-content/uploads/2023/10/unnamed-12.png)
Trademarks
CystalensTM,
CystaclearTM,
MoxiLensTM
![](https://freyaophthalmics.com/wp-content/uploads/2023/10/intellectual-property.png)
![](https://freyaophthalmics.com/wp-content/uploads/2023/10/unnamed-13.png)
![Patents](https://freyaophthalmics.com/wp-content/uploads/2023/10/unnamed-14.png)
Patents
5 issued patents and 4 PCT patent applications covering drug delivery contact lens through 2034. Provisionals submitted July 6, 2023.
![Rights](https://freyaophthalmics.com/wp-content/uploads/2023/10/unnamed-15.png)
Rights
Letter of intent for rights to a patented cornea crosslinking formulation